← Insider buys

Larry C Heaton II has bought stock on 2 days since Mar 2025

CEO at TSS, Inc., and 1 other company

SEC CIK 0001213207 · Filings on SEC.gov ↗

$57KBought
$0Sold
May 8Last buy

Larry C Heaton II's record

3 months after each buy, from the first price a copier could get.

1 buy has 3 months of prices so far. A record shows here at 3.

Companies

Every filing

2 filings since Mar 2025, newest first

About Larry C Heaton II

Larry C. Heaton is the Chief Executive Officer and President of Zomedica Corp., a veterinary health company creating point-of-care diagnostic and therapeutic products for companion animals ( He assumed the CEO role on October 31, 2021, following the retirement of the previous CEO ( With more than 35 years of executive leadership and operations experience in the therapeutic, medical device, and biotechnology industries, Heaton has demonstrated extensive expertise in business development, product commercialization, and management at both large-cap and early-stage companies ( He holds a Bachelor of Arts degree from Eastern Illinois University and is an inventor on several U.S. patents (

Throughout his career, Heaton has held leadership positions at numerous prominent medical device and biotechnology firms, including serving as President, CEO, and Director of Flowonix, Inc. (implantable drug-delivery systems), Cardiox Corporation (drug-device combination products), Vioptix Inc. (tissue oximetry), Curon Medical, Inc. (gastrointestinal disorder treatments), and Response Genetics, Inc. (oncology genomics) ( Earlier in his career, he spent 18 years at United States Surgical Corporation, culminating in his role as President and Chief Operating Officer from 1998 to 2000 ( Additionally, Heaton has served on the boards of several international medical societies and foundations, including the MITAC Board for NASA technology commercialization partnerships (

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.